Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance with a 40% increase in full-year revenue and a significant improvement in adjusted EBITDA. The Q&A section revealed positive sentiment towards future revenue growth, driven by strategic changes and anticipated ARR acceleration. Despite some execution risks, the company's strategic initiatives, including the Plexus partnership and AHA certification, are expected to enhance growth. The raised revenue guidance and positive cash flow expectations for 2026 further support a positive outlook, suggesting a likely stock price increase of 2% to 8%.
Annual Recurring Revenue (ARR) $120.5 million, reflecting growth of 21% year-over-year. The growth was fueled by new customer growth and expanding deployments across the customer base.
Q4 Revenue $38.5 million, up 32% year-over-year. Growth was driven by strong new customer acquisitions, continued expansion within existing customers, and a step-up of approximately $15 million in the second half of product revenue due to the decision to directly fulfill purchase subscriptions.
Full Year Revenue $145.9 million, representing growth of 40% year-over-year. Growth was primarily driven by strong demand and a $15 million year-over-year growth in revenue from the shift to directly fulfilling hardware portion of purchase subscription orders.
Adjusted EBITDA (Q4) $1.8 million, with an adjusted EBITDA margin of 4.7%. This is an improvement from $400,000 in the fourth quarter of the previous year, driven by revenue growth and operational leverage.
Adjusted EBITDA (Full Year) $11.1 million, with an adjusted EBITDA margin of 7.6%. This is a $32 million improvement from the prior year's loss of $21 million, driven by higher revenue and improved margins.
Remaining Performance Obligation (RPO) $293.4 million at the end of Q4, a 13% year-over-year increase. Growth was driven by upgrades to the Gen2 Express platform and solid end market demand.
Cash, Cash Equivalents, and Marketable Securities $69 million, an increase of $12.8 million sequentially in Q4. This increase reflects strong cash collection efforts and disciplined working capital management.
Weapons Detection as a Service: Evolv provides a comprehensive solution combining hardware, software, AI models, and on-site services. By the end of 2025, 8,000 systems were deployed, screening over 4 million people daily. The company also launched the eXpedite AI-based bag screening solution, which has been adopted by 65 customers in its first year.
Education Sector: Added 65 new education customers in 2025, screening approximately 300 million students and visitors. Expanded presence in schools and universities across the U.S.
Healthcare Sector: Partnered with the American Hospital Association, gaining access to nearly 5,000 member hospitals. Added notable customers like William P. Clements Jr. University Hospital and University of Oklahoma Medical Center.
Sports and Entertainment: Added 65 new customers in 2025, including 7 professional football teams. Upgraded systems for major venues like TD Garden and Crypto.com Arena.
Workplace Security: Secured multiple Fortune 500 companies, including a top 10 global bank and a Fortune 100 healthcare innovator.
Financial Performance: Achieved $145.9 million in revenue for 2025, a 40% year-over-year growth. Annual recurring revenue (ARR) reached $120.5 million, up 21% year-over-year. Adjusted EBITDA improved to $11.1 million from a $21 million loss in 2024.
Operational Efficiency: Shifted to direct fulfillment of purchase subscriptions, improving long-term revenue and cash flow despite short-term gross margin impacts.
Strategic Partnerships: Formed a partnership with the American Hospital Association to expand in the healthcare sector.
Product Innovation: Focused on AI advancements and expanding the product portfolio, including the successful launch of eXpedite.
Market Conditions: The global security environment is becoming increasingly complex, with escalating threat levels across public venues, schools, workplaces, and critical infrastructure. This increases the demand for scalable and reliable security solutions, but also presents challenges in meeting these heightened expectations.
Competitive Pressures: The discussion of generative AI and its potential to disrupt pure SaaS models highlights competitive pressures. While Evolv is not a pure SaaS company, the evolving technology landscape could pose challenges to maintaining its competitive edge.
Regulatory Hurdles: No explicit mention of regulatory hurdles was made in the transcript.
Supply Chain Disruptions: The company faces near-term gross margin headwinds due to the shift to direct fulfillment of purchase subscription orders, which impacts initial revenue and gross margin percentages.
Economic Uncertainties: The transcript does not explicitly mention economic uncertainties impacting the company.
Strategic Execution Risks: The transition to a direct fulfillment model, while beneficial in the long term, creates short-term challenges in gross margin and operational adjustments. Additionally, the company’s reliance on continued innovation in AI, hardware, and software to maintain its market position presents execution risks.
Revenue Expectations: The company is modeling full year 2026 revenue of $172 million to $178 million, representing year-over-year growth of approximately 18% to 22%. Revenue growth is expected to be driven by a 50-50 mix between purchase subscription and pure subscription.
Annual Recurring Revenue (ARR): The company expects to exit 2026 with ARR of approximately $145 million to $150 million, representing growth of about 20% to 25% year-over-year. The company ended 2025 with $120 million in ARR, providing a solid baseline for 2026.
Adjusted EBITDA Margins: The company is modeling full year adjusted EBITDA margins to expand from 7.6% in 2025 to the high single digits for 2026, despite a $1 million headwind on memory chip costs.
Deployment Expectations: The company expects to end 2026 with comfortably over 10,000 units deployed, up from 8,000 units at the end of 2025.
Market Trends and Strategic Plans: The company anticipates weapon screening to become standard infrastructure in certain types of buildings, similar to sprinkler systems and intrusion alarms. It plans to achieve this through relentless innovation in weapon detection accuracy, form factor, and cost.
Long-Term Financial Framework: The company plans to share more details about its long-term operating model, which is expected to show greater long-term leverage and adjusted EBITDA margins exceeding the previously stated range of 10% to 15%, at its 2026 Investor Day on June 9.
The selected topic was not discussed during the call.
The earnings call summary indicates strong financial performance with a 40% increase in full-year revenue and a significant improvement in adjusted EBITDA. The Q&A section revealed positive sentiment towards future revenue growth, driven by strategic changes and anticipated ARR acceleration. Despite some execution risks, the company's strategic initiatives, including the Plexus partnership and AHA certification, are expected to enhance growth. The raised revenue guidance and positive cash flow expectations for 2026 further support a positive outlook, suggesting a likely stock price increase of 2% to 8%.
The earnings call highlights strong financial performance with a 57% increase in revenue and positive adjusted EBITDA. Despite a decline in gross margin due to strategic shifts, the company has secured a significant contract and shows robust ARR growth. The Q&A session reveals positive sentiment towards strategic changes and future growth in various verticals. The partnership with Plexus and the education market expansion further support a positive outlook. However, some uncertainties remain regarding the pipeline of large contracts. Overall, the company is well-positioned for growth, suggesting a positive stock price movement.
The earnings call highlighted strong financial performance with revenue and ARR growth, a positive adjusted EBITDA, and improved cash flow. The Q&A revealed a balanced strategy with a shift towards subscriptions, strong market interest, and efficient inventory management. Although there were some uncertainties in management responses, the overall sentiment is positive, supported by strategic growth in diverse markets and a new certified pre-owned program. The stock price is likely to react positively over the next two weeks, driven by these factors.
The earnings call reveals strong financial performance with significant revenue growth (44% YoY) and positive EBITDA, indicating improved operational efficiency. Despite cash flow concerns due to one-time costs, the company's focus on subscription growth and strategic expansion in promising verticals like healthcare and sports is promising. The Q&A session highlighted optimism about new legislation driving demand and a robust subscription model. While no shareholder returns were announced, the overall outlook and strategic focus suggest a positive sentiment, likely resulting in a 2% to 8% stock price increase.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.